- Caliway Biopharmaceuticals' preclinical research was highlighted at the 25th Annual Congress of the Taiwan Medical Association for the Study of Obesity, held in conjunction with the 9th Japan-Korea-Taiwan Symposium on Obesity.
- The animal study explored CBL-514 in combination with a dual GLP-1/GIP receptor agonist (tirzepatide), evaluating body weight and adipose tissue–related parameters in animal models.
NEW TAIPEI CITY, Dec. 15, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company developing novel small-molecule therapeutics, announced that preclinical research involving CBL-514 was presented at the 25th Annual Congress of the Taiwan Medical Association for the Study of Obesity (TMASO 2025), held jointly with the 9th Japan–Korea–Taiwan Symposium on Obesity at National Taiwan University Hospital.
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56C`QmkAmk2 9C67lQ9EEADi^^>>2]AC?6HDH:C6]4@>^>65:2^abhfhag^r2=:H2J0q:@A92C>246FE:42=D0{@8@]9E>=Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk^2mk^Amk^5:Gm
kAm%96 4@?8C6DD 3C@F89E E@86E96C =625:?8 24256>:4 2?5 4=:?:42= 6IA6CED 7C@> %2:H2?[ y2A2?[ 2?5 z@C62 E@ 6I2>:?6 6>6C8:?8 492==6?86D :? @36D:EJ >2?286>6?E[ A2CE:4F=2C=J :? E96 4@?E6IE @7 H:56DAC625 25@AE:@? @7 kDEC@?8m:?4C6E:?\32D65 E96C2A:6Dk^DEC@?8m] $4:6?E:7:4 5:D4FDD:@?D :?4C62D:?8=J 6>A92D:K65 E96 ?665 7@C kDEC@?8m>F=E:\>6492?:D> DEC2E68:6Dk^DEC@?8m E92E 6IE6?5 36J@?5 2AA6E:E6 C68F=2E:@? 2?5 255C6DD 25:A@D6 E:DDF6 3:@=@8J[ 72E 5:DEC:3FE:@?[ 2?5 A@DE\EC62E>6?E H6:89E 5J?2>:4D]k^Am
kAmkDEC@?8m$4:6?E:7:4 r@?E6IEi q6J@?5 (6:89E {@DD %@H2C5 sFC23:=:EJ 2?5 u2E q:@=@8Jk^Am
kAmk^DEC@?8mp44@C5:?8 E@ AF3=:4=J C6A@CE65 C6>2C<D[ kDEC@?8msC] zF@\r9:? wF2?8k^DEC@?8m[ ':46 $FA6C:?E6?56?E @7 }2E:@?2= %2:H2? &?:G6CD:EJ w@DA:E2= 2?5 7@C>6C !C6D:56?E @7 3@E9 E96 %2:H2? |65:42= pDD@4:2E:@? 7@C E96 $EF5J @7 ~36D:EJ 2?5 E96 pD:2\!24:7:4 pDD@4:2E:@? 7@C E96 $EF5J @7 ~36D:EJ[ 9:89=:89E65 2 7:6=5\H:56 EC2?D:E:@? 7C@> D:?8=6\A2E9H2J @36D:EJ >@56=D E@H2C5 kDEC@?8m:?E68C2E65 7C2>6H@C<D 6?4@>A2DD:?8 6?6C8J 32=2?46[ 25:A@4JE6 7F?4E:@?[ 9@C>@?2= D:8?2=:?8[ 2?5 =@?8\E6C> >6E23@=:4 C:D<k^DEC@?8m]k^Am
kAm%96D6 A6CDA64E:G6D C67=64E 8C@H:?8 C64@8?:E:@? E92E kDEC@?8mH6:89E C63@F?5 7@==@H:?8 5:D4@?E:?F2E:@? @7 :?4C6E:?\32D65 E96C2A:6Dk^DEC@?8m C6>2:?D 2 4=:?:42==J C6=6G2?E 492==6?86[ 2?5 E92E kDEC@?8m72E BF2=:EJ 2?5 G:D46C2= 25:A@D:EJk^DEC@?8m >2J A=2J 2? :>A@CE2?E C@=6 :? =@?8\E6C> @FE4@>6D]k^Am
kAmkDEC@?8m!C64=:?:42= $EF5Ji rq{\d`c :? r@>3:?2E:@? (:E9 2 sF2= x?4C6E:? #646AE@C p8@?:DEk^Am
kAmk^DEC@?8mpD C6A@CE65 3J =@42= >65:2[ 2 kDEC@?8mAC64=:?:42= 2?:>2= DEF5J AC@A@D65 3J r2=:H2J q:@A92C>246FE:42=Dk^DEC@?8m H2D AC6D6?E65 5FC:?8 E96 4@?8C6DD 3J kDEC@?8msC] %KF\yF?8 r9@Fk^DEC@?8m[ pEE6?5:?8 !9JD:4:2? 2E }2E:@?2= %2:H2? &?:G6CD:EJ w@DA:E2=[ wD:?49F qC2?49]k^Am
kAm%96 DEF5J 6G2=F2E65 kDEC@?8mrq{\d`ck^DEC@?8m[ 2 D>2==\>@=64F=6 5CF8 E92E D6=64E:G6=J :?5F46D 25:A@4JE6 2A@AE@D:D[ :? 4@>3:?2E:@? H:E9 2 kDEC@?8m5F2= kDA2?mv{!\`k^DA2?m^vx! C646AE@C 28@?:DE WE:CK6A2E:56Xk^DEC@?8m :? 5:6E\:?5F465 @36D6 Wsx~X C2E >@56=D] %96 DEF5J 56D:8? :?4=F565 2? @3D6CG2E:@? A6C:@5 7@==@H:?8 :?4C6E:? H:E95C2H2=[ 6?23=:?8 2DD6DD>6?E @7 kDEC@?8mH6:89E >2:?E6?2?46 2?5 25:A@D6 E:DDF6 @FE4@>6Dk^DEC@?8m 36J@?5 24E:G6 :?4C6E:? EC62E>6?E]k^Am
kAm&?56C E96 DA64:7:4 4@?5:E:@?D @7 E96 2?:>2= >@56=[ E96 4@>3:?2E:@? 8C@FA 56>@?DEC2E65 DE2E:DE:42==J D:8?:7:42?E 5:776C6?46D 4@>A2C65 H:E9 :?4C6E:? >@?@E96C2AJ 24C@DD >F=E:A=6 A2C2>6E6CD[ :?4=F5:?8ik^Am
kF= EJA6lQ5:D4Qmk=:mkDEC@?8mq@5J\H6:89E C65F4E:@?k^DEC@?8mi –a`]gT W4@>3:?2E:@?X GD –`c]dT W>@?@E96C2AJXk^=:mk=:mkDEC@?8m!@DE\EC62E>6?E H6:89E C682:?k^DEC@?8mi Zad]aT GD Zdd]hT 27E6C :?4C6E:? H:E95C2H2=k^=:mk=:mkDEC@?8m$F34FE2?6@FD 72E C65F4E:@?k^DEC@?8mi –cb]dT GD –`d]cTk^=:mk=:mkDEC@?8m':D46C2= 72E C65F4E:@?k^DEC@?8mi –c`]eT GD –g]hTk^=:mk^F=m
kAmkDEC@?8m|6492?:DE:4 #2E:@?2=6i %2C86E:?8 p5:A@4JE6 }F>36C 2D 2 r@>A=6>6?E E@ x?4C6E:? %96C2AJk^Am
kAmk^DEC@?8msFC:?8 E96 AC6D6?E2E:@?[ sC] r9@F 56D4C:365 rq{\d`c 2D @776C:?8 2 kDEC@?8m>6492?:DE:42==J 5:DE:?4E 2AAC@249k^DEC@?8m 4@>A2C65 H:E9 :?4C6E:?\32D65 E96C2A:6D] (9:=6 :?4C6E:?D AC:>2C:=J >@5F=2E6 2AA6E:E6 2?5 6?6C8J :?E2<6[ kDEC@?8mrq{\d`c D6=64E:G6=J :?5F46D 2A@AE@D:D @7 25:A@4JE6Dk^DEC@?8m[ E96C63J C65F4:?8 25:A@4JE6 ?F>36C C2E96C E92? 25:A@4JE6 D:K6]k^Am
kAmrq{\d`c H2D 56D4C:365 2D E2C86E:?8 :?EC246==F=2C D:8?2=:?8 A2E9H2JD[ :?4=F5:?8 kDEC@?8ms*#z`qk^DEC@?8m[ =625:?8 E@ 564C62D65 2?E:\2A@AE@E:4 D:8?2=:?8 2?5 :?4C62D65 AC@\2A@AE@E:4 24E:G:EJ :? 25:A@4JE6D] uC@> 2 D4:6?E:7:4 A6CDA64E:G6[ E9:D >6492?:D> AC@G:56D 2 C2E:@?2=6 7@C 6IA=@C:?8 H96E96C kDEC@?8m4@>3:?:?8 :?4C6E:?\32D65 E96C2A:6D H:E9 286?ED E92E 5:C64E=J >@5F=2E6 25:A@D6 E:DDF6 3:@=@8Jk^DEC@?8m 4@F=5 :?7=F6?46 72E 5:DEC:3FE:@? 2?5 A@DE\EC62E>6?E H6:89E 5J?2>:4D]k^Am
kAmsC] r9@F 6>A92D:K65 E92E 255:E:@?2= C6D62C49 :D C6BF:C65 E@ 56E6C>:?6 @AE:>2= EC62E>6?E D6BF6?4:?8[ 5FC2E:@?[ 2?5 A2E:6?E D6=64E:@?[ 2D H6== 2D E@ 2DD6DD A@E6?E:2= 4=:?:42= C6=6G2?46 :? 9F>2?D]k^Am
kAmkDEC@?8mx>A=:42E:@?D 7@C uFEFC6 ~36D:EJ #6D62C49 2?5 sCF8 s6G6=@A>6?Ek^Am
kAmk^DEC@?8ms:D4FDD:@?D 2E %|p$~ a_ad C67=64E65 2 3C@256C 6G@=FE:@? :? @36D:EJ C6D62C49 E@H2C5 kDEC@?8m5FC23:=:EJ @7 C6DA@?D6[ G:D46C2= 72E C65F4E:@?[ 2?5 >2:?E6?2?46 DEC2E68:6D 7@==@H:?8 A92C>24@=@8:4 H6:89E =@DDk^DEC@?8m] (:E9:? E9:D 4@?E6IE[ E96 AC6D6?E65 AC64=:?:42= 52E2 H6C6 5:D4FDD65 2D 4@?EC:3FE:?8 E@ @?8@:?8 D4:6?E:7:4 6IA=@C2E:@? @7 kDEC@?8m>F=E:\>6492?:D> E96C2A6FE:4 A2C25:8>Dk^DEC@?8m[ A2CE:4F=2C=J :? 4@>3:?2E:@? H:E9 :?4C6E:?\32D65 286?ED]k^Am
kAmr2=:H2J ?@E65 E92E E96 DEF5J DFAA@CED 7FCE96C :?G6DE:82E:@? :?E@ H96E96C kDEC@?8m25:A@4JE6\E2C86E65 >6492?:D>D >2J 4@>A=6>6?E 6I:DE:?8 :?4C6E:? A:A6=:?6Dk^DEC@?8m[ :?4=F5:?8 A@E6?E:2= C@=6D :? kDEC@?8m4@>3:?2E:@? @C >2:?E6?2?46\A92D6 DEC2E68:6Dk^DEC@?8m[ DF3;64E E@ 7FEFC6 4=:?:42= 6G2=F2E:@?]k^Am
kAmkDEC@?8mp3@FE rq{\d`ck^Am
kAmk^DEC@?8mrq{\d`c[ 2 d_dW3XW`X 2?5 7:CDE\:?\4=2DD D>2==\>@=64F=6 5CF8 56G6=@A65 3J r2=:H2J[ :D E96 H@C=5VD 7:CDE :?;64E23=6 =:A@=JD:D 5CF8 E92E :?5F46D 25:A@4JE6 2A@AE@D:D E@ C65F46 DF34FE2?6@FD 72E :? E2C86E65 2C62DkDEC@?8m H:E9 ?@k^DEC@?8m kDEC@?8mDJDE6>2E:4 D276EJ C:D<D :56?E:7:65k^DEC@?8mkDEC@?8m 2?5 H6==k^DEC@?8mkDEC@?8m E@=6C2k^DEC@?8mkDEC@?8mE65]k^DEC@?8m k^Am
kAmpD @7 |2J a_ad[ `_ 4=:?:42= EC:2=D H:E9 2 E@E2= @7 da_ DF3;64ED 92G6 366? 4@>A=6E65 H:E9 2== kDEC@?8m677:424J 2?5 D276EJ 6?5A@:?ED >6Ek^DEC@?8m]k^Am
kAmr2=:H2J :D 4FCC6?E=J :?G6DE:82E:?8 >F=E:A=6 :?5:42E:@?D 7@C rq{\d`c[ :?4=F5:?8 ?@?\DFC8:42= 72E C65F4E:@?[ >@56C2E6\E@\D6G6C6 46==F=:E6[ 2?5Â kDEC@?8mH6:89E >2?286>6?Ek^DEC@?8m]Â rq{\d`cs[ E96 D2>6 24E:G6 A92C>246FE:42= :?8C65:6?ED Wp!xDX 3FE F?56C 5:776C6?E 7@C>F=2E:@?[ :D 36:?8 DEF5:65 7@C 255:E:@?2= :?5:42E:@?D DF49 2D s6C4F>VD 5:D62D6 2?5 >@C6]k^Am
kAmkDA2?mkDEC@?8m|65:2 r@?E24Ek^DEC@?8mik^Am
kAmk^DA2?mkDA2?mk2 9C67lQ>2:=E@i:Co42=:H2J3:@A92C>2]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm:Co42=:H2J3:@A92C>2]4@>k^2mk^DA2?mk^Am
kAmkDEC@?8mp3@FE r2=:H2J q:@A92C>246FE:42=Dk^DEC@?8mk^Am
kAmr2=:H2J q:@A92C>246FE:42=D Wr2=:H2JX :D 2 4=:?:42=\DE286 3:@A92C>246FE:42= 4@>A2?J 5C:G6? E@ 3C62<E9C@F89 5CF8 5:D4@G6CJ @7 ?@G6= D>2==\>@=64F=6 E96C2A6FE:4D] {:DE65 @? E96 %2:H2? tI492?86 W%($t\eh`hX[ r2=:H2J 2:>D E@ 364@>6 2? :??@G2E:G6 A92C>246FE:42= =6256C :? 26DE96E:4 >65:4:?6 2?5 @E96C 5:D62D6D] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:Ei k2 9C67lQ9EEADi^^HHH]42=:H2J3:@A92C>2]4@>^6?^Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm9EEADi^^HHH]42=:H2J3:@A92C>2]4@>^6?^k^2mk^Am
kAmkDEC@?8ms:D4=2:>6Ck^Am
kAmk^DEC@?8m%9:D 2CE:4=6 2?5 C6=2E65 :?7@C>2E:@? @? E9:D D:E6 4@?E2:? 7@CH2C5\=@@<:?8 DE2E6>6?ED] %96 7@CH2C5\=@@<:?8 :?7@C>2E:@? C6BF:C6D E96 r@>A2?J E@ >2<6 ?F>6C@FD 2DDF>AE:@?D 2?5 :D DF3;64E E@ :?96C6?E C:D<D[ F?46CE2:?E:6D[ 2?5 @E96C 724E@CD E92E 2C6 36J@?5 E96 4@?EC@= @7 E96 r@>A2?J H9:49 >2J 42FD6 24EF2= C6DF=ED[ A6C7@C>2?46 @C 249:6G6>6?ED E@ 36 >2E6C:2==J 5:776C6?E 7C@> 7FEFC6 C6DF=ED[ A6C7@C>2?46 @C 249:6G6>6?ED 6IAC6DD65 @C :>A=:65 3J DF49 7@CH2C5\=@@<:?8 DE2E6>6?ED] %96 r@>A2?J F?56CE2<6D ?@ @3=:82E:@? E@ E:>6=J :?7@C>[ FA52E6[ @C C6G:D6 E96 :?7@C>2E:@? @? E9:D D:E6 :7 4:C4F>DE2?46D D9@F=5 492?86]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lwzcgbbbU2>AjD5la_ad\`a\`eQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^42=:H2J\3:@A92C>246FE:42=D\AC6D6?ED\AC64=:?:42=\C6D62C49\DFAA@CE:?8\2\>F=E:\>6492?:D>\2AAC@249\E@\H6:89E\>2?286>6?E\2E\E>2D@\a_ad\b_aecb_da]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^42=:H2J\3:@A92C>246FE:42=D\AC6D6?ED\AC64=:?:42=\C6D62C49\DFAA@CE:?8\2\>F=E:\>6492?:D>\2AAC@249\E@\H6:89E\>2?286>6?E\2E\E>2D@\a_ad\b_aecb_da]9E>=k^2mk^Am
kAm$~&#rt r2=:H2Jk^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lwzcgbbbU2>Aj%C2?D>:DD:@?0x5la_ad`a`e__bd!#0}t($0&$!#00000wzcgbbbU2>Ajs2E6x5la_ad`a`eQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.